PolyPeptide Group
Company overview
| Headquarters | Baar, Zug, Switzerland |
| Phone number | +41435020580 |
| Website | |
| NAICS | 3254 |
| SIC | 283 |
| Keywords | Commercial Manufacturing, Gmp Peptides, R&D, Personalized Medicine, Innovation & Technology, Green Chemistry, Regulatory Support, Active Pharmaceutical Ingredients, Peptides, Oligonucleotides, Generic Peptides, Gmp Compliance, Non-Gmp Peptides, Generic Api'S, Cosmetic Peptides, Individualized Peptides |
| Founded | 1996 |
| Employees | 1001-2000 |
| Socials |
PolyPeptide Group Email Formats
PolyPeptide Group uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@polypeptide.com), used 69.6% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@polypeptide.com | 69.6% |
{first initial}.{last name} | j.doe@polypeptide.com | 28.8% |
About PolyPeptide Group
PolyPeptide Group AG with its consolidated subsidiaries (“PolyPeptide”) is a focused Contract Development & Manufacturing Organization (CDMO) which specializes in the development and manufacturing of synthetic peptides and oligonucleotides used as active pharmaceutical ingredients (API) or intermediates in therapeutic products. It also produces a range of generic peptides and peptides used in cosmetics. The Group mainly serves pharmaceutical and biotech companies. By supporting its customers, PolyPeptide contributes to the health of millions of patients across the world. PolyPeptide provides its offering from pre-clinical through to commercial stages. Its active custom projects pipeline reflects the opportunities from novel drug therapies in development to fight both widespread and rare diseases. Established in 1952, PolyPeptide today runs a global network of six GMP-certified facilities in Europe, the U.S. and India. PolyPeptide’s shares (SIX: PPGN) are listed on SIX Swiss Exchange. Find out more about our current vacancies at: https://polypeptide.teamtailor.com/
PolyPeptide Group revenue & valuation
| Annual revenue | $1,434,100,000 |
| Revenue per employee | $1,052,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $4,589,100,000 |
| Total funding | $161,800,000 |
Employees by Management Level
Total employees: 1001-2000
Employees by Department
PolyPeptide Group has 667 employees across 18 departments.
Departments
Number of employees
Funding Data
Explore PolyPeptide Group's funding history, including investment rounds, total capital raised, and key backers.
PolyPeptide Group Tech Stack
Discover the technologies and tools that power PolyPeptide Group's digital infrastructure, from frameworks to analytics platforms.
Security
Security
Form builders
JavaScript libraries
JavaScript libraries
JavaScript libraries
CDN
WordPress themes
JavaScript libraries
Miscellaneous
Programming languages
Denmark
Saudi Arabia
United States
United Kingdom
Italy
PolandFrequently asked questions
Key Contact at PolyPeptide Group
4.8
40,000 users
